Hepatitis C Articles (HCV)
Back
	GS-7977 HCV Transplant Studies       An Open-Label Study to Explore the Clinical Efficacy of GS 7977 With Ribavirin Administered Pre-Transplant in Preventing Hepatitis C Virus (HCV) Recurrence Post-Transplant   Study to Investigate GS-7977 and Ribavirin for 24 Weeks in Subjects With Recurrent Chronic HCV Post Liver Transplant   This study is currently recruiting participants. Verified November 2012 by Gilead Sciences           View Older Articles   Back to Top   www.natap.org